1un5: Difference between revisions
Jump to navigation
Jump to search
m Protected "1un5" [edit=sysop:move=sysop] |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:1un5.png|left|200px]] | [[Image:1un5.png|left|200px]] | ||
{{STRUCTURE_1un5| PDB=1un5 | SCENE= }} | {{STRUCTURE_1un5| PDB=1un5 | SCENE= }} | ||
===ARH-II, AN ANGIOGENIN/RNASE A CHIMERA=== | ===ARH-II, AN ANGIOGENIN/RNASE A CHIMERA=== | ||
{{ABSTRACT_PUBMED_14756559}} | {{ABSTRACT_PUBMED_14756559}} | ||
==About this Structure== | ==About this Structure== | ||
[[1un5]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1UN5 OCA]. | [[1un5]] is a 1 chain structure of [[Ribonuclease]] with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1UN5 OCA]. | ||
==See Also== | |||
*[[Ribonuclease|Ribonuclease]] | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:014756559</ref><ref group="xtra">PMID:009918722</ref><ref group="xtra">PMID:001698454</ref><references group="xtra"/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Pancreatic ribonuclease]] | [[Category: Pancreatic ribonuclease]] |
Revision as of 16:48, 27 July 2012
ARH-II, AN ANGIOGENIN/RNASE A CHIMERAARH-II, AN ANGIOGENIN/RNASE A CHIMERA
Template:ABSTRACT PUBMED 14756559
About this StructureAbout this Structure
1un5 is a 1 chain structure of Ribonuclease with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See AlsoSee Also
ReferenceReference
- ↑ Holloway DE, Chavali GB, Hares MC, Baker MD, Subbarao GV, Shapiro R, Acharya KR. Crystallographic studies on structural features that determine the enzymatic specificity and potency of human angiogenin: Thr44, Thr80, and residues 38-41. Biochemistry. 2004 Feb 10;43(5):1230-41. PMID:14756559 doi:10.1021/bi035654+
- ↑ Leonidas DD, Shapiro R, Allen SC, Subbarao GV, Veluraja K, Acharya KR. Refined crystal structures of native human angiogenin and two active site variants: implications for the unique functional properties of an enzyme involved in neovascularisation during tumour growth. J Mol Biol. 1999 Jan 22;285(3):1209-33. PMID:9918722 doi:10.1006/jmbi.1998.2378
- ↑ Harper JW, Fox EA, Shapiro R, Vallee BL. Mutagenesis of residues flanking Lys-40 enhances the enzymatic activity and reduces the angiogenic potency of angiogenin. Biochemistry. 1990 Aug 7;29(31):7297-302. PMID:1698454